Abstract
The use of a new tined lead electrode for sacral neuromodulation (SNS) was evaluated in a European study including 127 patients with chronic voiding dysfunction. The tined lead can be implanted during the first stage of the SNS procedure, which makes a longer test period possible before implanting the pulse generator in a second stage. Implantation of the tined lead was performed under local anaesthesia in 89% of patients. Screening lasted on average 30 days. Screening with the tined lead was considered successful by the physicians in 77% of patients (n=72). In 74% of first stage patients (n=70), at least 50% improvement in the main symptoms versus baseline was obtained. This was sustained for up to 6 weeks. All of these patients received the pulse generator in a second stage. The outcome of this study supports the use of the tined lead electrode as a screening tool in SNS therapy.
This is a preview of subscription content, access via your institution.



References
- 1.
Abrams P, Blaivas JG, Fowler CJ et al. (2003) The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91:355–359
- 2.
Bosch R, Groen J (2000) Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol 163:1219–1222
- 3.
Chai TC, Mamo GJ (2001) Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 58:786–790
- 4.
Everaert K, Kerckhaert W, Caluwaerts H et al. (2004) A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol 45:649–654
- 5.
Everaert K, Plancke H, Lefevere F et al. (1997) The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br J Urol 79:702–707
- 6.
Janknegt RA, Weil EHJ, Eerdmans PH (1997) Improving neuromodulation technique for refractory voiding dysfunction: two-stage implant. Urology 78:39–46
- 7.
Jonas U, Fowler CJ, Chancellor MB et al. (2001) Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 165:15–19
- 8.
Kinchen KS, Burgio K, Diokno AC et al. (2003) Factors associated with women’s decisions to seek treatment for urinary incontinence. J Women’s Health 12:687–698
- 9.
Miner PB (2004) Economic and personal impact of fecal and urinary incontinence. Gastroenterology 126 [Suppl 1]:S8-S13
- 10.
Scheepens WA, Weil EH, Van Koeveringe GA et al. (2001) Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation—a multicentre study. Eur Urol 40:434–438
- 11.
Schmidt RA, Senn E, Tanagho EA (1990) Functional evaluation of sacral nerve root integrity. Report of a technique. Urology 35:388–392
- 12.
Shaker HS, Hassouna M (1998) Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol 159:1476–1478
- 13.
Siegel SW (2002) Sacral nerve stimulation: PNE. In: Jonas U, Grünewald V (eds) New perspectives in sacral nerve stimulation. Martin Dunitz, London, pp 99–106
- 14.
Spinelli M, Giardiello G, Gerber M et al. (2003) New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 170:1905–1907
- 15.
Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140:1331–1339
- 16.
Tanago EA, Schmidt RA (1991) In: Krane RJ, Siroky MB (eds) Clinical neurology, 2nd edn. Little Brown, Boston, pp 643–648
- 17.
Van Kerrebroeck P, Van Voskuilen A, Lycklama A Nyeholt AA, Dijkema H, Bemelmans B, Fall M, Fowler C, Das A, Milam D, Siegel S, Van den Hombergh U, PAS Study Group (2004) Long-term results of Interstim therapy for voiding disorders demonstrate sustained efficacy and acceptable safety profile. Eur Urol [Suppl] 3:170
- 18.
Van Voskuilen A, Van Kerrebroeck P, Dijkema H, Bemelmans B, Lycklama A Nijholt A, Fall M, Jonas U, Fowler CJ, Das AK, Milam D, Siegel SW, Van den Hombergh U (2004) Lasting improvement is demonstrated in patients with voiding disorders treated with sacral nerve stimulation. J Urol 171 [Suppl 4]: 328
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spinelli, M., Weil, E., Ostardo, E. et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol 23, 225–229 (2005). https://doi.org/10.1007/s00345-005-0502-8
Received:
Accepted:
Published:
Issue Date:
Keywords
- Lower urinary tract dysfunctions
- Sacral neuromodulation
- Minimally invasive
- Overactive bladder
- Urinary retention
- Tined lead